352 results
Page 11 of 18
8-K
EX-10.7
yhfp9s9c4k z6
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
v9akbe91i
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.8
nzdornbd
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
pv1pf3h
17 Aug 11
Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
12:00am
8-K
EX-99.1
ooilxtsle2rdy51
28 Jul 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
2xrakks 95l
21 Jun 11
Other Events
12:00am
8-K
EX-99.1
wrkdvf7bvz31re rj0r4
27 Apr 11
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
12:00am
8-K
EX-99.1
e3wz4xoyx uqo
26 Apr 11
Sanofi-aventis and Regeneron Report Positive Phase III Results with ZALTRAP™ (aflibercept) in Second-line Metastatic Colorectal Cancer
12:00am
8-K
EX-99.1
e6oe4of rc
18 Apr 11
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
12:00am